Table 1.

Baseline demographic and clinical characteristics

Schedule A (n = 13)Schedule B (n = 21)
Gender, n (%)
    Male8 (62)10 (48)
    Female5 (38)11 (52)
Mean (range) age, y62 (47-81)63 (36-82)
ECOG performance status, n (%)
    06 (46)10 (48)
    17 (54)11 (52)
Smoking status, n (%)
    Current smoker1 (8)2 (10)
    Exsmoker9 (69)15 (71)
    Never smoked3 (23)4 (19)
Histology, n (%)
    Adenocarcinoma5 (38)15 (71)
    Squamous cell carcinoma3 (23)3 (14)
    Large cell carcinoma/unclassified5 (38)3 (14)
Median (range) number of prior systemic therapies2 (1-4)2 (1-4)
Patients receiving at least one prior EGFR inhibitor, n (%)4 (31)5 (24)

Abbreviation: ECOG, Eastern Cooperative Oncology Group.